Medical professionals are always searching for new and more effective ways to record and analyze health data.  Additionally, physicians and other medical specialists are often on the hunt for new devices that can help refine medical procedures, improve patient recovery efforts, and boost overall public health.
WIRED Heath is an annual event that takes place in London, UK. It’s a popular forum for medical technology manufacturers, inventors and entrepreneurs to showcase their latest technological innovations to the health care community. The following four devices are breakthroughs that have been revealed at WIRED Health:
Twenty-five to thirty percent of United States consumers are diagnosed with patent foramen ovale (PFO)—also known as an atrial septal defect, which is a birth defect that causes a hole to form within the heart. Unfortunately, PFO patients are at increased risk of suffering from strokes.  Physicians can usually identify the cause of most strokes, which are commonly caused by improperly managed high blood pressure, thinning blood vessels caused by cholesterol deposits, or scar tissue and blood clots caused by an abnormal heart rhythm called atrial fibrillation. However, for instances where physicians cannot identify the cause of the stroke, they believe that PFOs allow a blood clot to travel to the brain.
In October 2016, the U.S. Food and Drug Administration (FDA) approved the Amplatzer PFO Occluder device. Scientists engineered the device to reduce the risk of a second stroke in patients that physicians believe suffered an initial stroke due to a PFO. The device provides physicians with a nonsurgical alternative to closing the holes in the heart.
In September of 2016, the FDA granted approval for the Medtronic MiniMed 670G for use in antonymous insulin monitoring and delivery for consumers over the age of 14 who have been diagnosed with Type 1 diabetes.  Consumers with Type 1 diabetes do not produce a low, continuous supply of insulin called basal or background insulin.
The MiniMed 670G system includes a body sensor that measures glucose levels, a wearable insulin pump and an infusion patch. The medical device uses a closed loop system, also called artificial pancreas, which regulates insulin with little user intervention, requiring compensation solely for meals. The device may prove particularly beneficial for consumers who must monitor their glucose levels continuously and might provide a newfound freedom.
GyroGear, a wearable technology firm, has applied its technology to assist consumers who live with tremors.  The condition is the most common involuntary movement among those diagnosed with the condition. Physicians have defined tremors as “an unintentional, rhythmic muscle movement involving to-and-fro movements (oscillations) of one or more parts of the body” and can result from Parkinson’s disease or prescribed medications, making it difficult for consumers to perform many common tasks.
GyroGlove uses a gyroscope in its glove design. Although simple, despite efforts to find an alternative, company representatives have been unable to match the balance, simplicity and reliability of the gyroscope. Once the device is ready for use, it will help consumers counteract tremors without the need for individual calibration.
In the United States, 7,000 rare diseases affect 30 million consumers, and 75 percent of those consumers are children. Researchers are continually working to find cures for these illnesses. However, efforts to make a difference have proven unfruitful so far. In part, researchers have difficulty making progress due to a lack of available data.
The Aparito monitoring device solves this dilemma by allowing researchers to acquire continuous patient health “snapshots,” recording metrics such as blood pressure, heart rate, movement, body temperature, and sleep habits. Researchers can then assess this information along with other environmental variables to develop a full overview of a patient’s health condition. The device also works with software that allows physicians to track prescription and appointment compliance.
The foremost objectives of any health care organization are to produce positive patient outcomes and improve overall community health.  This will require the health care leaders of the future to possess proficient skill in discovering what medical innovations help patients heal. More importantly, these leaders must have the entrepreneurialism and foresight to solve problems using new and effective medical technologies.
To learn to speak the language of health law and distinguish your role as a leader with specialized health care compliance expertise, look to pursue a Master’s in Health Law and Policy from Hofstra Law.
Image source: http://gyrogear.co/gyroglove